INS and metabolic disease: Dyslipidemia, characterized by high levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides, as well as low levels of high-density lipoprotein cholesterol (HDL-C), is a major risk factor for metabolic disorders such as IFG, because it disrupts lipid metabolism and insulin action at the molecular level [37].